Johan Hansson

Title: Innovations of Johan Hansson

Introduction

Johan Hansson is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of biotechnology, particularly in the development of modified chimeric superantigens. With a total of 2 patents, his work has implications for therapeutic methods in immunology.

Latest Patents

Hansson's latest patents include a groundbreaking invention titled "Modified Chimeric Superantigens and Their Use." This patent describes a conjugate that combines a target-seeking moiety with a modified superantigen. The innovation involves replacing an amino acid residue in a superantigen region that determines binding to T cell receptors (TCR) while retaining the ability to activate specific T cell subsets. The modified superantigen can be a chimeric form that interchanges amino acid residues between various wild-type superantigens. Additionally, the patent outlines a therapeutic method utilizing these modified superantigens and an antibody preparation with mutated cysteine residues to enhance pharmaceutical applications.

Career Highlights

Throughout his career, Johan Hansson has worked with prominent companies in the biotechnology sector, including Active Biotech AB and Pharmacia AB. His experience in these organizations has contributed to his expertise in the development of innovative therapeutic solutions.

Collaborations

Hansson has collaborated with notable colleagues such as Mikael Dohlsten and Per Antonsson. These partnerships have likely enriched his research and development efforts in the field of biotechnology.

Conclusion

Johan Hansson's contributions to the field of biotechnology through his patents and collaborations highlight his role as an influential inventor. His work on modified chimeric superantigens showcases the potential for advancements in therapeutic methods.